Already have an account? Sign In
eVariant, founded in 2008 and headquartered in Farmington, Connecticut, is a healthcare technology company that combines marketing automation and data integration services to help hospitals and healthcare systems acquire and retain patients. The company's solutions focus on service line growth, improving provider network utilization, and extending patient lifetime value.
Since its inception, eVariant has raised a total of $91.26 million in funding, demonstrating investor interest in its innovative approach to healthcare marketing and data analytics. The company's growth trajectory and unique position in the healthcare technology sector have made it a subject of interest for potential investors.
In January 2020, eVariant was acquired by Healthgrades, a leading online resource for comprehensive information about physicians and hospitals. This acquisition may have implications for any potential IPO plans, as the company is now part of a larger organization.
While there is no current news or official information regarding eVariant's IPO prospects, the healthcare technology sector continues to attract significant attention from investors. Companies that offer innovative solutions for patient acquisition and retention, like eVariant, are often viewed as potential candidates for public offerings.
It's important to note that any discussions about eVariant's potential IPO remain speculative at this time. Factors such as market conditions, company performance, and strategic decisions by Healthgrades as the parent company would all play a role in any future IPO considerations.
Investors interested in the healthcare technology sector and companies like eVariant should continue to monitor official announcements and financial news for the most up-to-date and accurate information regarding potential investment opportunities.
Already have an account? Sign In
While eVariant's IPO prospects remain uncertain, investors interested in the healthcare technology sector don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like eVariant, with lower minimum investments than traditional private equity channels. This allows you to diversify your portfolio and potentially benefit from the growth of innovative healthcare tech companies before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.